J&J Increases European Consumer Stake With Merck Buyout
This article was originally published in The Tan Sheet
Executive Summary
Merck says it will seek new partners for future Rx-to-OTC switch drugs in Europe following Johnson & Johnson's buyout of the company's half of their European consumer health joint venture